Literature DB >> 28913595

Health Professionals "Make Their Choice": Pharmaceutical Industry Leaders' Understandings of Conflict of Interest.

Quinn Grundy1, Lisa Tierney2, Christopher Mayes2, Wendy Lipworth2.   

Abstract

Conflicts of interest, stemming from relationships between health professionals and the pharmaceutical industry, remain a highly divisive and inflammatory issue in healthcare. Given that most jurisdictions rely on industry to self-regulate with respect to its interactions with health professionals, it is surprising that little research has explored industry leaders' understandings of conflicts of interest. Drawing from in-depth interviews with ten pharmaceutical industry leaders based in Australia, we explore the normalized and structural management of conflicts of interest within pharmaceutical companies. We contrast this with participants' unanimous belief that the antidote to conflicts of interest with health professionals were "informed consumers." It is, thus, unlikely that a self-regulatory approach will be successful in ensuring ethical interactions with health professionals. However, the pharmaceutical industry's routine and accepted practices for disclosing and managing employees' conflicts of interest could, paradoxically, serve as an excellent model for healthcare.

Entities:  

Keywords:  Conflict of interest; Disclosure; Neoliberalism; Pharmaceutical industry; Professionalism

Mesh:

Year:  2017        PMID: 28913595     DOI: 10.1007/s11673-017-9804-y

Source DB:  PubMed          Journal:  J Bioeth Inq        ISSN: 1176-7529            Impact factor:   1.352


  17 in total

1.  Conflict of interest and the public trust.

Authors:  C D DeAngelis
Journal:  JAMA       Date:  2000-11-01       Impact factor: 56.272

2.  A social science perspective on gifts to physicians from industry.

Authors:  Jason Dana; George Loewenstein
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

3.  Pharmaceutical virtue.

Authors:  Emily Martin
Journal:  Cult Med Psychiatry       Date:  2006-06

4.  "But doctors do it...": nurses' views of gifts and information from the pharmaceutical industry.

Authors:  Annemarie Jutel; David B Menkes
Journal:  Ann Pharmacother       Date:  2009-05-26       Impact factor: 3.154

5.  Nurse practitioners' perceptions and participation in pharmaceutical marketing.

Authors:  Nancy Crigger; Kristen Barnes; Autumn Junko; Sarah Rahal; Casey Sheek
Journal:  J Adv Nurs       Date:  2009-03       Impact factor: 3.187

6.  Understanding bias--the case for careful study.

Authors:  Lisa Rosenbaum
Journal:  N Engl J Med       Date:  2015-05-14       Impact factor: 91.245

Review 7.  Interactions between physicians and the pharmaceutical industry: what does the literature say?

Authors:  J Lexchin
Journal:  CMAJ       Date:  1993-11-15       Impact factor: 8.262

8.  Understanding financial conflicts of interest.

Authors:  D F Thompson
Journal:  N Engl J Med       Date:  1993-08-19       Impact factor: 91.245

9.  Physician attitudes toward industry: a view across the specialties.

Authors:  Deborah Korenstein; Salomeh Keyhani; Joseph S Ross
Journal:  Arch Surg       Date:  2010-06

10.  Financial Relationships between Organizations That Produce Clinical Practice Guidelines and the Biomedical Industry: A Cross-Sectional Study.

Authors:  Paul Campsall; Kate Colizza; Sharon Straus; Henry T Stelfox
Journal:  PLoS Med       Date:  2016-05-31       Impact factor: 11.069

View more
  1 in total

1.  Power to the People?

Authors:  Michael A Ashby; Bronwen Morrell
Journal:  J Bioeth Inq       Date:  2017-11-15       Impact factor: 1.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.